Cargando…
Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis
Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system and a leading cause of neurological disability. The complex immunopathology and variable disease course of multiple sclerosis have limited effective treatment of all patients. Altering the metabolism of immune...
Autores principales: | Shriver, Leah P., Manchester, Marianne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216566/ https://www.ncbi.nlm.nih.gov/pubmed/22355598 http://dx.doi.org/10.1038/srep00079 |
Ejemplares similares
-
Fatty Acid Metabolism and T Cells in Multiple Sclerosis
por: Pompura, Saige L., et al.
Publicado: (2022) -
Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate
por: Aharoni, Rina, et al.
Publicado: (2019) -
Role of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and Humans
por: Huang, Chao-Wei, et al.
Publicado: (2016) -
Astrocytes Undergo Metabolic Reprogramming in the Multiple Sclerosis Animal Model
por: das Neves, Sofia Pereira, et al.
Publicado: (2023) -
Platelet Inhibition by Low-Dose Acetylsalicylic Acid Reduces Neuroinflammation in an Animal Model of Multiple Sclerosis
por: Vogelsang, Anna, et al.
Publicado: (2021)